Patents Assigned to XORTX THERAPEUTICS, INC.
  • Xanthine oxidase inhibitor formulations
    Patent number: 11406713
    Abstract: Disclosed herein are methods and compositions for involving a xanthine oxidase inhibitor that has enhanced solubility. The compositions described herein include a xanthine oxidase inhibitor combined with an organic base. The compositions can be used to treat a disease or medical condition that involves elevated uric acid levels.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: August 9, 2022
    Assignee: XORTX THERAPEUTICS, INC.
    Inventor: Allen Davidoff